FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileAethlon Medical, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
AEMD
Aethlon Medical, Inc. Stock AnalysisComprehensive stock analysis for Aethlon Medical, Inc. (AEMD) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisAEMD
AEMD
Aethlon Medical, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
AEMD
  1. Home
  2. Stocks
  3. Aethlon Medical, Inc.

Aethlon Medical, Inc.

🇺🇸AEMD•NASDAQ

Aethlon Medical, Inc.

🇺🇸AEMD•NASDAQ
Market cap
$2.69M

Your view on AEMD

Mkt Cap
$2.69M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Aethlon Medical, Inc.

Industry
Medical - Devices
Sector
Healthcare
CEO
James B. Frakes
Headquarters
11555 Sorrento Valley Road, San Diego, CA, US
Industry
Medical - Devices
Sector
Healthcare
CEO
James B. Frakes
Headquarters
11555 Sorrento Valley Road, San Diego, CA, US
Description

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States.

The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer.

The company was founded in 1999 and is based in San Diego, California.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Aethlon Medical, Inc.. Starting points for Aethlon Medical, Inc.: EPS -$8.01, beta 1.40 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Aethlon Medical, Inc.. Trailing twelve-month EPS for Aethlon Medical, Inc. stands at -$8.01. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 20, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$1.50

average of analysts' targets

 

$1.50

Low $1.50

Median $1.50

High $1.50

 

Analyst Ratings

Hold3 ratings
  • Strong Buy0
  • Buy1
  • Hold2
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrJun 2021Next QtrSep 2021Current YearFY Mar 2027Next YearFY Mar 2028
Avg. estimate−$104.00−$120.00−$6.49−$1.91
Low estimate−$104.00−$120.00−$11.93−$1.91
High estimate−$104.00−$120.00−$1.04−$1.91
No. of analysts9721
Year-ago EPS——−$10.611—
Growth————

1Year-ago EPS includes one-time items; growth not shown.

Revenue Estimate

RevenueCurrent QtrJun 2021Next QtrSep 2021Current YearFY Mar 2027Next YearFY Mar 2028
Avg. estimate$175000.00$208500.00$0.00$0.00
Low estimate$175000.00$208500.00$0.00$0.00
High estimate$175000.00$208500.00$0.00$0.00
No. of analysts5500
Year-ago revenue——$0.00—
Growth————
Recent analyst actions15 rating and price-target changes, latest Aug 18, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider; as of Nov 20, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Aethlon Medical, Inc.. Aethlon Medical, Inc. has reported as a listed company since 1999. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold AEMD17 companies
Compare AEMD with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
ALURAllurion Technologies Inc.HealthcareMedical - Devices$11.0M
CODXCo-Diagnostics, Inc.HealthcareBiotechnology$1.5M
ERNAErnexa Therapeutics Inc.HealthcareBiotechnology$2.7M
LNAILunai Bioworks Inc.HealthcareBiotechnology$829,677
NVNOenVVeno Medical CorporationHealthcareMedical - Devices$4.0M
TNONTenon Medical, Inc.HealthcareMedical - Devices$526,243
More Medical - Devices companies
TickerTypeCompanySectorExchangeMkt cap
NPCENeuroPace, Inc.HealthcareNASDAQ$283.2M
NSPRInspireMD, Inc.HealthcareNASDAQ$31.9M
NSYSNortech Systems IncorporatedHealthcareNASDAQ$32.8M
NUMDNu-Med Plus, Inc.HealthcareOTC$1.3M
NUWENuwellis, Inc.HealthcareNASDAQ$353,130
NVCRNovoCure LimitedHealthcareNASDAQ$1.3B
NWCINewCardio, Inc.HealthcareOTC$3,315
NXLNexalin Technology, Inc.HealthcareNASDAQ$1.8M
OCPNFOlympus CorporationHealthcareOTC$10.6B
ODYYOdyssey Health, Inc.HealthcareOTC$5.5M
OFIXOrthofix Medical Inc.HealthcareNASDAQ$269.4M
Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Aethlon Medical, Inc., and how their positions are changing. At a $2.7M market value, institutional positions materially move Aethlon Medical, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Aethlon Medical, Inc. executives and directors. Shares of Aethlon Medical, Inc. have traded between $3.90 and $84.80 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Aethlon Medical, Inc.. Coverage tracks Aethlon Medical, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Aethlon Medical, Inc.

AEMD AnalysisWeak
Past
1
Growth
1
Health
5
Profit
1
Value
1

News

Latest Market News